Ascendis Pharma(ASND)
Focus: Ascendis Pharma is a public biotech company specializing in prodrug therapies across oncology, endocrinology, ophthalmology, neurology, and rare diseases. Founded in 2007 and headquartered in Palo Alto, CA, the company has achieved market validation with one launched product and a robust late-stage pipeline.
Profile data last refreshed 10h ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Open Jobs
63+11 this month
Growing — net +11 jobs in 30d
34 jobs added vs 23 removed. Steady team buildout.
Should You Work at Ascendis Pharma?
AI assessmentAscendis offers solid early-to-mid stage biotech exposure with a validated platform and multiple near-term shots on goal, but recent workforce restructuring and modest hiring signal near-term uncertainty.
Why Work Here
- One FDA-approved product (YUVIWEL/navepegritide) already launched with 20 years of patent protection (LOE 2042), demonstrating successful execution and revenue generation
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Growing
Growth16.0yr
First and only approved CNP receptor agonist for achondroplasia, launched recently with 17+ years of patent protection providing long commercial runway.
Help build intelligence for Ascendis Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.